USE OF A CHIMERIC, HUMANIZED ANTI-HUMAN NGF MONOCLONAL ANTIBODY CAPABLE OF BINDING hNGF WITH HIGH AFFINITY IN THE MANUFACTURE OF A MEDICAMENT FOR USE IN TREATING AN NGF - RELATED INFLAMMATORY CONDITION OTHER THAN INFLAMMATORY CONDITION ASSOCIATED WITH THE EFFECT OF NGF ON THE NEURONAL SYSTEM

摘要

The present invention relates generally to methods of using anti-NGF antibodies in the treatment of various NGF-related disorders. The methods are effective in treating these disorders in a patient without having a significant adverse effect on the immune system of the patient.